The AMR Narrative

Facebook X-twitter Instagram Linkedin Youtube
Menu

Tweetchat: Why is AMR everyone’s problem?

Tweetchat: Why is AMR everyone’s problem?

Info

 

In partnership with the Center for Infectious Disease Research and Policy – Antimicrobial Stewardship (CIDRAP-ASP) we invite you to join us on the 11th of April 2023 for a general discussion about why AMR impacts everyone.

 

Summary

Antimicrobial resistance (AMR) is an increasing concern that affects everyone globally. AMR occurs when microorganisms such as bacteria, viruses, fungi, and parasites become resistant to the medications, also called antimicrobials, which were designed to treat them. These also means that antimicrobials become less effective.

Patients with AMR infections may require lengthier treatments and longer hospital stays. AMR is associated with increased morbidity and mortality rates, and higher healthcare costs.

One of the most concerning characteristics of AMR is that it can affect anyone, regardless of age, gender, or location. Patients with weakened immune systems, such as the elderly, young children, and those with chronic illnesses, are particularly vulnerable to the effects of AMR. Equally, patients undergoing chemotherapy or other immunosuppressive treatments are also at higher risk of developing AMR infections. It is crucial that we safeguard these life-saving medicines so that they continue to work.

To tackle AMR, it is important to utilise a multidimensional approach that includes both individual and societal changes following a One Health approach. One Health incorporates human and animal health, food production, and farming as well as the environment.

Patients can help to reduce the spread of resistant infections by practicing good hygiene, taking antimicrobials only when necessary, and completing the full course of treatment as prescribed. Healthcare providers can also play a critical role by prescribing antimicrobials cautiously and applying infection prevention and control measures to reduce the spread of resistant microorganisms in all clinical settings.

However, we choose to play a role in reducing the spread and evolution of AMR, every one of our contributions matter.

Questions:

T1: What is Antimicrobial Resistance (AMR) and why is it a problem for everyone?
T2: What can patients and the public do to reduce Antimicrobial Resistance (AMR)?
T3: What can health professionals do to reduce Antimicrobial Resistance (AMR)?
T4: Why is Antimicrobial Resistance (AMR) an issue in food safety and farming and what impact can that have on patients and the public?
T5: What can the public do to tackle Antimicrobial Resistance (AMR) including in realms like policy, advocacy, education, etc.?
CT: Any thoughts you would like to add about why Antimicrobial Resistance (AMR) is everyone’s problem?

 

How to participate:
Join us for a 60-minute Twitter chat with our panel experts. All stakeholders are welcome.

Start your answers with T1, T2, T3, T4, T5 or CT for transcript purposes.
Answer only after the moderator prompts. Questions will be prompted every 10 minutes but keep answers coming using the relevant T and number. Both panel experts and the public are encouraged to answer.
Use the #theAMRnarrative hashtag in all your tweets so that you are visible to others in the chat and captured on transcript.

 

Notes: Prior to the event, review the University of Minnesota’s Social Media House Rules for a code of conduct applicable to this event.

Info
Category: ,
Location: Twitter
Date: April 11, 2023
Duration: 1 Day

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.